Gentian Diagnostics AS Profit Margin

Gentian Diagnostics AS (GENT.OL) currently reports a profit margin of -2.64% as of September 2026. That compares with 24.8% in the prior-year period — down 110.7% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Gentian Diagnostics AS's profit margin history and peer comparisons.

Gentian Diagnostics AS's profit margin decreased from 24.8% to -2.64% — a 110.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gentian Diagnostics AS's profit margin of -2.64% is lower than the its sector sector average of 13.23%. That is roughly 120.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Gentian Diagnostics AS's current -2.64% should be judged against industry norms (sector average: 13.23%) and against GENT.OL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2.64%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Gentian Diagnostics AS, and consider following GENT.OL for alerts when major investors trade the stock.